REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,279,088 | +127808.8% | 12,545 | +46363.0% | 0.01% | – |
Q2 2022 | $1,000 | -87.5% | 27 | -88.4% | 0.00% | – |
Q1 2022 | $8,000 | +700.0% | 233 | +796.2% | 0.00% | – |
Q4 2021 | $1,000 | -92.3% | 26 | -80.0% | 0.00% | – |
Q3 2021 | $13,000 | -43.5% | 130 | -18.8% | 0.00% | – |
Q2 2021 | $23,000 | +666.7% | 160 | +384.8% | 0.00% | – |
Q1 2021 | $3,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |